JAKARTA - PT Medikaloka Hermina Tbk (HEAL), the managing company of Hermina Hospitals, will convert 175.37 million shares through its Management and Employee Stock Option Program (MESOP) Phase II starting from next week (30/10).

Aristo Setiawidjaja, Director of HEAL, mentioned that this corporate action plan will last for a week, concluded on November 3, 2023.

This plan refers to the announcement made on July 29, 2021, regarding pre-listing of HEAL’s shares. The number of shares involved in MESOP was 222.97 million shares, with options distributed on May 20, 2020. The vesting period ended on May 20, 2020, while the active period of those options will last until May 19, 2023. The options’ exercise period had been done twice a year, in June 2020 and November-December 2021.

The exercise price is set to IDR 622.20 per share. Considering the number of converted shares, the raised funds will reach IDR 109.18 billion.

Last week (20/10), the shares were being traded at its peak of IDR 1,460 per share. It indicates an over 100% increase in HEAL’s price within the past two years.

As of September 30, 2023, HEAL’s directors who own over 5% of total listed shares of 14.96 billion include Binsar Parasian of 5.8% and Yulisat Khiat of 11.71%. Other directors that own shares less than 5% are Hasmoro, President Director of HEAL, of 4.06%, and Aristo Setiawidjaja of 0.33%. (LK/ZH)